M. Rokhman, Bustanul Arifin, Z. Zulkarnain, Saidah Rauf, D. Perwitasari
{"title":"糖尿病患者使用FINDRISC的文献计量学分析:2005-2021","authors":"M. Rokhman, Bustanul Arifin, Z. Zulkarnain, Saidah Rauf, D. Perwitasari","doi":"10.33084/bjop.v5i3.3267","DOIUrl":null,"url":null,"abstract":"Research on risk factors for diabetes (DM) is growing. Identification of these risk factors aims to prevent DM as early as possible. This study intends to identify the utilization of the Finnish diabetes risk score (FINDRISC) and its development using bibliometric analysis. The keywords “FINDRISC AND Diabetes” were used to search for articles published in 2005-2021 in PubMed. A total of 249 articles were analyzed based on the number of publications per year, journals that publish the papers, number of publications by author and year of publication, number of publications by affiliation and year of publication, number of publications by country of origin of authors and year of publication, number of keywords, number of citations, types of articles, specific topics, and theme mapping. The data visualization was obtained from the Scopus database and the VOSviewer and Biblioshiny applications. Despite the increase in publications, the number of publications on FINDRISC in DM patients is still very few per year, with 92.8% being the primary study. Based on clusters of the country of origin, publications are still dominated by researchers from countries in the European region, and the researchers intensely relate to each other through citations. Research themes related to FINDRISC are not limited to DM risk factors. This study is the first study of a bibliometric analysis of the utilization of FINRISC in DM patients. The analysis results can be used to evaluate existing research gaps and identify future research opportunities.","PeriodicalId":9118,"journal":{"name":"Borneo Journal of Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bibliometric Analysis of the Utilisation of FINDRISC in Patients with Diabetes: 2005-2021\",\"authors\":\"M. Rokhman, Bustanul Arifin, Z. Zulkarnain, Saidah Rauf, D. Perwitasari\",\"doi\":\"10.33084/bjop.v5i3.3267\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Research on risk factors for diabetes (DM) is growing. Identification of these risk factors aims to prevent DM as early as possible. This study intends to identify the utilization of the Finnish diabetes risk score (FINDRISC) and its development using bibliometric analysis. The keywords “FINDRISC AND Diabetes” were used to search for articles published in 2005-2021 in PubMed. A total of 249 articles were analyzed based on the number of publications per year, journals that publish the papers, number of publications by author and year of publication, number of publications by affiliation and year of publication, number of publications by country of origin of authors and year of publication, number of keywords, number of citations, types of articles, specific topics, and theme mapping. The data visualization was obtained from the Scopus database and the VOSviewer and Biblioshiny applications. Despite the increase in publications, the number of publications on FINDRISC in DM patients is still very few per year, with 92.8% being the primary study. Based on clusters of the country of origin, publications are still dominated by researchers from countries in the European region, and the researchers intensely relate to each other through citations. Research themes related to FINDRISC are not limited to DM risk factors. This study is the first study of a bibliometric analysis of the utilization of FINRISC in DM patients. The analysis results can be used to evaluate existing research gaps and identify future research opportunities.\",\"PeriodicalId\":9118,\"journal\":{\"name\":\"Borneo Journal of Pharmacy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-08-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Borneo Journal of Pharmacy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33084/bjop.v5i3.3267\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Borneo Journal of Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33084/bjop.v5i3.3267","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
对糖尿病(DM)危险因素的研究越来越多。识别这些危险因素的目的是尽早预防糖尿病。本研究旨在通过文献计量学分析确定芬兰糖尿病风险评分(FINDRISC)的应用及其发展。关键词“FINDRISC AND Diabetes”用于检索2005-2021年在PubMed发表的文章。根据每年发表论文的数量、发表论文的期刊、作者发表论文的数量和出版年份、所属机构发表论文的数量和出版年份、作者原籍国和出版年份、关键词数量、引用次数、文章类型、具体主题、主题映射等,共分析了249篇论文。数据可视化由Scopus数据库、VOSviewer和Biblioshiny应用程序获得。尽管发表量有所增加,但每年关于糖尿病患者FINDRISC的出版物数量仍然很少,其中92.8%是主要研究。在原籍国集群的基础上,出版物仍然以欧洲地区的研究者为主,研究者之间通过引文关系密切。与FINDRISC相关的研究主题并不局限于糖尿病的危险因素。本研究是首个对糖尿病患者使用FINRISC进行文献计量学分析的研究。分析结果可用于评估现有的研究差距和确定未来的研究机会。
Bibliometric Analysis of the Utilisation of FINDRISC in Patients with Diabetes: 2005-2021
Research on risk factors for diabetes (DM) is growing. Identification of these risk factors aims to prevent DM as early as possible. This study intends to identify the utilization of the Finnish diabetes risk score (FINDRISC) and its development using bibliometric analysis. The keywords “FINDRISC AND Diabetes” were used to search for articles published in 2005-2021 in PubMed. A total of 249 articles were analyzed based on the number of publications per year, journals that publish the papers, number of publications by author and year of publication, number of publications by affiliation and year of publication, number of publications by country of origin of authors and year of publication, number of keywords, number of citations, types of articles, specific topics, and theme mapping. The data visualization was obtained from the Scopus database and the VOSviewer and Biblioshiny applications. Despite the increase in publications, the number of publications on FINDRISC in DM patients is still very few per year, with 92.8% being the primary study. Based on clusters of the country of origin, publications are still dominated by researchers from countries in the European region, and the researchers intensely relate to each other through citations. Research themes related to FINDRISC are not limited to DM risk factors. This study is the first study of a bibliometric analysis of the utilization of FINRISC in DM patients. The analysis results can be used to evaluate existing research gaps and identify future research opportunities.